Share this
clinical trials: how dangerous are they?
by Neoteryx Microsampling on Jul 17, 2019 5:15:00 AM
Clinical trials are essential to the advancement of medicine. New drugs and devices are tested on people as the last step before the drug or device becomes available to those who need it.
In double-blind studies, clinical trials are run so that no one knows which medication is being given. If you've enrolled in such an experiment, you might get the test drug or a standard medication or you might get a placebo. Neither the doctor nor you will know what it is until the test is over.
If you get a standard drug for the condition, there is little danger from being in the trial.
If you get the placebo, your condition will be untreated and may get out of control. That is why you have to have frequent checkups with the doctor. If your blood pressure or diabetes is getting worse, the doctor will probably take you out of the experiment and put you back on your regular medicines. Placebos are usually made of starch or sugar and have no side effects or actions.
If you get the experimental drug, there are some possible risks.
- The drug may not work as expected. Myriad factors - from genetics, to lifestyle, to luck - can affect your response to a medication.
- You might experience a side effect of the drug. Every drug can have side effects, even over-the-counter medicines and herbal remedies. Most side effects are minor, such as nausea, diarrhea or drowsiness. But some can be serious. Make sure you understand all possible side effects and be alert for them.
- You may react to the drug with an allergic reaction, such as hives. However, there are several more serious allergic reactions which require emergency medical treatment. Know your own allergy profile and be aware of any possible reactions as they arise.
Your safety is paramount. If you are enrolled in a clinical trial, you will be monitored carefully for these problems and removed from the experiment if you can’t tolerate a drug or present an allergic reaction.
While there are some risks associated with clinical trials, they are relatively minor and rare. More commonly, participants complain of the inconvenience, including frequent trips to the doctor for evaluation and to the laboratory for blood draws.
Clinical trials are important. Facilitators, researchers, and innovators such as Neoteryx are doing everything they can to make subjects' lives easier and safer. More and more clinical trials use microsampling for blood collection. Instead of going to the lab and waiting to get stuck several times, you can collect your sample at home. Just a finger-prick and a collection kit and you can mail your sample in. It's more comfortable and more convenient.
Share this
- Microsampling (206)
- Research, Remote Research (119)
- Venipuncture Alternative (106)
- Clinical Trials, Clinical Research (83)
- Mitra® Device (74)
- Therapeutic Drug Monitoring, TDM (51)
- Dried Blood Spot, DBS (38)
- Biomonitoring, Health, Wellness (31)
- Infectious Disease, Vaccines, COVID-19 (24)
- Blood Microsampling, Serology (22)
- Decentralized Clinical Trial (DCT) (22)
- Omics, Multi-Omics (20)
- Specimen Collection (17)
- Toxicology, Doping, Drug/Alcohol Monitoring, PEth (17)
- hemaPEN® Device (13)
- Preclinical Research, Animal Studies (12)
- Skin Microsampling, Microbiopsy (12)
- Pharmaceuticals, Drug Development (9)
- Harpera Device (5)
- Industry News, Microsampling News (5)
- Antibodies, MAbs (3)
- Company Press Release, Product Press Release (3)
- Environmental Toxins, Exposures (1)
- December 2024 (2)
- November 2024 (1)
- October 2024 (3)
- September 2024 (1)
- June 2024 (1)
- May 2024 (1)
- April 2024 (4)
- March 2024 (1)
- February 2024 (2)
- January 2024 (4)
- December 2023 (3)
- November 2023 (3)
- October 2023 (3)
- September 2023 (3)
- July 2023 (3)
- June 2023 (2)
- April 2023 (2)
- March 2023 (2)
- February 2023 (2)
- January 2023 (3)
- December 2022 (2)
- November 2022 (3)
- October 2022 (4)
- September 2022 (3)
- August 2022 (5)
- July 2022 (2)
- June 2022 (2)
- May 2022 (4)
- April 2022 (3)
- March 2022 (3)
- February 2022 (4)
- January 2022 (5)
- December 2021 (3)
- November 2021 (5)
- October 2021 (3)
- September 2021 (3)
- August 2021 (4)
- July 2021 (4)
- June 2021 (4)
- May 2021 (4)
- April 2021 (3)
- March 2021 (5)
- February 2021 (4)
- January 2021 (4)
- December 2020 (3)
- November 2020 (5)
- October 2020 (4)
- September 2020 (3)
- August 2020 (3)
- July 2020 (6)
- June 2020 (4)
- May 2020 (4)
- April 2020 (3)
- March 2020 (6)
- February 2020 (3)
- January 2020 (4)
- December 2019 (5)
- November 2019 (4)
- October 2019 (2)
- September 2019 (4)
- August 2019 (4)
- July 2019 (3)
- June 2019 (7)
- May 2019 (6)
- April 2019 (5)
- March 2019 (6)
- February 2019 (5)
- January 2019 (8)
- December 2018 (3)
- November 2018 (4)
- October 2018 (7)
- September 2018 (6)
- August 2018 (5)
- July 2018 (8)
- June 2018 (6)
- May 2018 (5)
- April 2018 (6)
- March 2018 (4)
- February 2018 (6)
- January 2018 (4)
- December 2017 (2)
- November 2017 (3)
- October 2017 (2)
- September 2017 (4)
- August 2017 (2)
- July 2017 (4)
- June 2017 (5)
- May 2017 (6)
- April 2017 (6)
- March 2017 (5)
- February 2017 (4)
- January 2017 (1)
- July 2016 (3)
- May 2016 (1)
- April 2016 (2)
No Comments Yet
Let us know what you think